Dr. David P. Rapaport, founder and Medical Director of Coolspa, created Coolspa to address the need in New York for a patient-centric, high quality facility where clients could experience top-tier body contouring in a relaxed, comfortable setting. Most importantly, the Coolspa ethos is based on patient education. Only by being educated about their condition, all relevant treatment options, advantages and disadvantages of those options, can patients make optimal treatment decisions.
While contouring tones down the whole body according to your requirement, body sculpting focuses on specific body parts to be treated. For instance, if you have excess fat on your skin under your arm, you can get it removed through body sculpting without the need for any surgery. Other body parts which can be focused upon to treat with body sculpting include but is not limited to, inner thighs, outer thighs, abdomen, sides and flanks, large, broad areas of fat etc.
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.
Now, you can finally achieve your weight loss goals without the risk or downtime of major bariatric surgery. The new, FDA-approved device, Orbera™, is a small gastric balloon that is gently placed into the stomach so you feel fuller longer and can practice portion control with greater success. Orbera™ is a non-surgical solution to help jump start your weight loss and maintain a healthier lifestyle.
1 July 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.